Skip to main content
. 2020 May 13;11(5):545. doi: 10.3390/genes11050545

Table 1.

Baseline characteristics of the patients.

Characteristic F ≤ 2 (N = 39) F = 3 (N = 6) P-Value
Male (%) 23 (59.0) 2 (33.3) 0.462
Age, year 41.0 (33.5–54.5) 60.5 (57.0–64.0) 0.015 *
Steatosis 0.284
5–33% (%) 13 (33.3) 4 (66.7)
>33–66% (%) 16 (41.0) 1 (16.7)
>66% (%) 10 (25.6) 1 (16.7)
Lobular inflammation 0.496
<2 foci per 200 × field (%) 25 (64.1) 4 (66.7)
2–4 foci per 200 × field (%) 12 (30.8) 1 (16.7)
>4 foci per 200 × field (%) 2 (5.1) 1 (16.7)
Ballooning 0.144
None (%) 8 (20.5) 0 (0.0)
Few ballooned cells (%) 20 (51.3) 2 (33.3)
Many cells/prominent ballooning (%) 11 (28.2) 4 (66.7)
Nonalcoholic steatohepatitis 31 (79.5) 6 (100.0) 0.516
NAS ≥ 5 (%) 17 (43.6) 4 (66.7) 0.538
Weight, kg 79.0 (70.0–97.0) 72.0 (59.3–84.0) 0.226
BMI, kg/m2 27.8 (26.1–32.4) 27.9 (26.5–30.4) 0.694
Systolic blood pressure, mmHg 138 (127–148) 132.0 (132–133) 0.573
Hypertension 19 (48.7) 4 (66.7) 0.704
Diabetes 10 (25.6) 5 (83.3) 0.020 *
Platelets, ×103/mm 240.0 (200.0–286.0) 167.0 (142.0–192.0) 0.023
AST, IU/L 63.0 (51.5–82.0) 119.0 (74.0–165.0) 0.019 *
ALT, IU/L 96.0 (70.5–128.5) 76.0 (58.0–173.0) 0.593
Bilirubin, mg/dL 0.6 (0.5–0.7) 0.7 (0.7–0.9) 0.681
Albumin, g/dL 4.6 (4.4–4.8) 4.5 (4.1–4.7) 0.350
Gamma GTP, mg/dL 60.0 (46.0–123.0) 61.0 (52.0-92.0) 0.820
Creatinine, mg/dL 0.8 (0.7–0.9) 0.7 (0.7–0.9) 0.494
Fasting blood glucose, mg/dL 108.0 (98.0–123.0) 118.5 (113.0–127.0) 0.142
Total cholesterol, mg/dL 183.0 (164.0–204.0) 167.5 (160.0–211.0) 0.687
HDL, mg/dL 38.5 (31.0–49.0) 48.5 (43.0–56.0) 0.098
LDL, mg/dL 118.5 (93.0–145.0) 108.5 (100.0–151.0) 0.857
Triglyceride, mg/dL 183.0 (123.0–295.0) 102.0 (70.0–118.0) 0.005 *

NAS, nonalcoholic fatty liver disease activity score; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, guanosine triphosphate; HDL, high density lipoprotein; LDL, low density lipoprotein. * P-value < 0.05.